Patent Assignment
Reel/Frame 048383/0260
Assignment of Assignor's Interest
Recorded: 2019-02-20
Pages: 3
Assignor
BOCH, RONALD ERWIN
Executed: 2012-03-20
Assignee
QLT INC.
SUITE 101 - 887 GREAT NORTHERN WAY, VANCOUVER, V5T 4T5, CANADA
Covered Property
(1)
Pharmaceutical Formulations Comprising 9-Cis-Retinyl Esters in a Lipid Vehicle
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Feb 20, 2019
From: QLT INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 048383/0577 →
Assignment of Assignor's Interest
Feb 21, 2019
From: NOVELION THERAPEUTICS INC.
To: RETINAGENIX, LLC
Reel/Frame 048403/0004 →
Assignment of Assignor's Interest
Mar 20, 2020
From: RETINAGENIX, LLC
To: RETINAGENIX THERAPEUTICS, INC.
Reel/Frame 052175/0176 →
Assignment of Assignor's Interest
Apr 7, 2021
From: RETINAGENIX THERAPEUTICS, INC.
To: RETINAGENIX HOLDINGS LLC
Reel/Frame 055857/0001 →
Assignment of Assignor's Interest
Aug 9, 2022
From: RETINAGENIX HOLDINGS LLC
To: ELUMINEX BIOSCIENCES (SUZHOU) LIMITED
Reel/Frame 060763/0001 →